Skip to content

Interest Expense at other companies

ALN
Alnylam PharmaceuticalsALNY
$69.29M+18.8%
Regenxbio logo
RegenxbioRGNX
$8.71M+1.6%
Opko Health logo
Opko HealthOPK
$10.94M-29.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$1.43M-22.7%
Precigen logo
PrecigenPGEN
$2.91M+290,700%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.4M+17.6%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's interest expense?
Tectonic Therapeutics (TECX) reported interest expense of $8K in Q1 2026.
How has Tectonic Therapeutics's interest expense changed year-over-year?
Tectonic Therapeutics's interest expense decreased by 60.0% year-over-year, from $20K to $8K.
What is the long-term trend for Tectonic Therapeutics's interest expense?
Over 2 years (2023 to 2025), Tectonic Therapeutics's interest expense has grown at a -35.6% compound annual growth rate (CAGR), from $152K to $63K.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.